Real-time Estimate
Tradegate
04:08:03 2024-07-12 am EDT
5-day change
1st Jan Change
3.495
EUR
-0.14%
-0.14%
+10.60%
Sales 2024 *
476M
518M
Sales 2025 *
490M
533M
Capitalization
1.09B
1.18B
Net income 2024 *
89M
96.71M
Net income 2025 *
92M
99.97M
EV / Sales 2024 *
2.31
x
Net Debt
2024
*
9.8M
10.65M
Net cash position
2025
*
17.9M
19.45M
EV / Sales 2025 *
2.19
x P/E ratio 2024 *
12.1
x
P/E ratio 2025 *
11.8
x
Employees
1,748
Yield 2024 *
4.38%
Yield 2025 *
4.38%
Free-Float
91.13%
Duration
1 day 1 week 1 month 3 months 6 months 1 year 5 years 10 years
Period
5 minutes 15 minutes 30 minutes 1 hour 1 day 1 week 1 month 1 year
Style
CandleStick End-of-day OHLC Mountain
Dynamic Chart
FAES FARMA : Faes Farma is now receiving the long-awaited attention from investors
May. 23
FAES FARMA : Q1 beat; full-year guidance re-affirmed
Apr. 26
Faes Farma, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024
Apr. 14
CI
FAES FARMA : Q4 profitability exceeded expectations
Feb. 27
Faes Farma, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
Feb. 27
CI
FAES FARMA : Mixed Q3; markets need more from Faes to be convinced
23-10-25
Faes Farma, S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023
23-10-14
CI
FAES FARMA : A soft Q2, as expected; guidance maintained
23-08-01
Faes Farma, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023
23-07-28
CI
FAES FARMA : Increased R&D focus and inflationary pressures to hold back near-to-medium term earnings
23-07-12
FAES FARMA : A healthy start to 2023
23-05-08
Faes Farma, S.A. completed the acquisition of NovoSci.
23-05-02
CI
Faes Farma, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-02
CI
FAES FARMA : 2022 guidance met + positive view maintained
23-03-06
Faes Farma, S.A. Reports Earnings Results for the Full Year Ended December 31, 2022
23-02-28
CI
More news
IN DIRETTA DAI MERCATI: Amplifon, Buzzi, Acs, Davide Campari, Diasorin, Enel, Eni, Webuild, Apple, Ferrari...
May. 03
EN DIRECTO DESDE LOS MERCADOS: BBVA, Acciona, Acs, Sabadell, Amadeus It, ArcelorMittal, Grifols, Inditex, Faes Farma, Apple, Ferrari...
May. 03
IN DIRETTA DAI MERCATI: Tenaris, BBVA, Amplifon, Unicaja, IAG, Stellantis, Ariston, Porsche, Anglo American, BHP, BMW, Tesla, Alphabet...
Apr. 29
EN DIRECTO DESDE LOS MERCADOS: BBVA, Iberdrola, Unicaja, IAG, Prosegur, Porsche, Anglo American, BHP, BMW, Tesla, Alphabet...
Apr. 29
Cinco valores que se deben tener muy en cuenta por técnico este miércoles
Apr. 24
More news 1 day +0.23%
1 week +0.57%
Current month -2.91%
1 month -5.41%
3 months +10.58%
6 months +11.11%
Current year +10.76%
More quotes
Managers
Title Age Since
Chief Executive Officer
-
-
Chief Executive Officer
-
-
Director of Finance/CFO
-
-
Members of the board
Title Age Since
Director/Board Member
65
18-06-18
Chairman
-
91-05-15
Director/Board Member
-
94-06-25
More insiders
Date
Price
Change
Volume
24-07-12
3.495
-0.14%
12 744
24-07-11
3.5
+0.29%
448,560
24-07-10
3.49
+0.29%
70,126
24-07-09
3.48
-0.71%
183,436
24-07-08
3.505
+0.14%
300,712
Delayed Quote
BME, July 11, 2024 at 11:35 am EDT
More quotes
Faes Farma SA is a Spain-based company engaged in the pharmaceutical industry. The Company specializes in the research, production, distribution and sale of prescription and generic drugs, over-the-counter (OTC) medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The Companyâs research lines are mainly focused on the development of new drugs for the treatment of allergy, venous insufficiency and irritable bowel syndrome, among others. In addition, it provides animal nutrition products. The Company operates in Spain, Portugal, Chile and Mexico, among others. It controls a number of subsidiaries, such as Laboratorios Vitoria SA, Laboratorios Veris SA, Lazlo International SA, Ingaso Farm SLU, Esfion SA and Biotecnet I MAS D SA.
More about the company
Mean consensus
UNDERPERFORM
Average target price
3.725
EUR
Spread / Average Target
+6.43%
Consensus
1st Jan change
Capi.
+10.76% 1.18B +60.25% 841B +38.56% 625B -4.49% 360B +18.30% 327B +9.64% 300B +14.15% 242B +3.11% 228B +16.98% 227B +12.87% 174B
Other Pharmaceuticals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1